Abstract
The purpose of the study was to evaluate the efficacy and the toxicity of levamisole given for 1 year to 16 children suffering from minimal change primary nephrosis who were relapsing frequently. The overall results showed that under levamisole the relapse rate decreased by 55% and the steroid requirements by 50%. After cessation of levamisole administration, most children (11/16) relapsed again. A second course of levamisole treatment reduced the relapse rate significantly once again. At the dosage of 2.5 mg/kg given every other day for 1 year or more, no side effects of levamisole were observed. It is concluded that levamisole does not cure nephrosis but reduces the incidence of relapses for the period it is administered. It also reduces the steroid requirements without any important side effects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barnett HL (1975) The natural and treatment history of glomerular diseases in children — what can we learn from international cooperative studies. A report of the International Study of Kidney Disease in Children. Proc 6th Int Cong Nephrol, Florence. Karger, Basel, pp 470–485
McDonald J, Murphy AV, Arneil GC (1974) Long-term assessment of cyclophosphamide therapy for nephrosis in children. Lancet I: 980–988
Grupe WE, Makher SP, Ingelfinger JR (1976) Chlorambucil treatment of frequently relapsing nephrotic syndrome. N Engl J Med 295: 746
Behrman RE, Vaughan VC III (1987) Nelson textbook of pediatrics, 13th edn. Saunders, Philadelphia, pp 1224–1225
Tanphaichitr P, Tanphaichitr D, Sureeratanan J (1980) Treatment of nephrotic syndrome with levamisole. J Pediatr 96: 490:493
Mehta KP, Ali V, Kutty PM, Shah J (1983) Immunological study of minimal change nephrotic syndrome with special reference to levamisole therapy. Eur J Pediatr 140: 189
Niaudet P, Drachman R, Gagnadoux MF, Broyer M (1984) Treatment of idiopathic nephrotic syndrome with levamisole. Acta Pediatr Scand 73: 637–641
Pecorato C, Usberti M, Guida B, Grumetto L, Carlonaro L, Pinto A, Saravo MT, Gaggiotti A (1985) Levamisole in the treatment of frequently relapsing nephrotic syndrome. Kidney Int 28: 295
Mehta KP, Ali M, Kolhatkar U (1986) Immunoregulatory treatment for minimal change nephrotic syndrome. Arch Dis Child 61: 153–158
Drachman R, Schlesinger M, Mor J, Alon U, Etzioni A, Ohali M, Shapiro H, Drukker A (1986) Immunoregulation with Levamisole in children with idiopathic nephrotic syndrome. Pediatr Nephrol 1: C46
International Study of Kidney Disease in Children (1979) Nephrotic cyndrome in children: a randomized trial comparing two predinisone regimens in steroid-responsive patients who relapse early. J Pediatr 95: 235–243
Prieur AM, Buriot D, Lefur JM, Griscelli C (1978) Possible toxicity of Levamisole in children with rheumatoid arthritis. J Pediatr 93: 304–305
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mongeau, JG., Robitaille, P.O. & Roy, F. Clinical efficacy of levamisole in the treatment of primary nephrosis in children. Pediatr Nephrol 2, 398–401 (1988). https://doi.org/10.1007/BF00853429
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00853429